Literature DB >> 19471935

Delay before the hepatocyte phase of Gd-EOB-DTPA-enhanced MR imaging: is it possible to shorten the examination time?

Utaroh Motosugi1, Tomoaki Ichikawa, Licht Tominaga, Hironobu Sou, Katsuhiro Sano, Shintaro Ichikawa, Tsutomu Araki.   

Abstract

AIM: To examine if it is possible to shorten the examination time of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB)-enhanced MRI by omitting hepatocyte-phase images of 20-min delay time (Im-20) for detecting focal liver lesions.
MATERIALS AND METHODS: Four hundred ninety-five malignant focal liver lesions observed on Im-20 in 265 patients were included. The hepatocyte phase was obtained 10 min (Im-10) and 20 min (Im-20) after Gd-EOB injection. Liver enhancement was evaluated using a 4-point scale [excellent/good/poor/non-diagnostic; visual liver-spleen contrast (V-LSC)] and a quantitative liver-spleen contrast ratio (Q-LSC). Two radiologists evaluated lesion conspicuity for assessing the sensitivity of lesion detection. As Im-20 was used as the standard of reference for the lesions, Im-20 artificially had 100% sensitivity.
RESULTS: The results showed that although sensitivities and Q-LSC significantly increased from Im-10 to Im-20 (sensitivity/mean Q-LSC: Im-5, 81%/1.4 Im-10, 96%/1.7: Im-20, 100%/1.9), the sensitivity of Im-10 achieved 100% (the same as Im-20) in patients with good/excellent V-LSC or Q-LSC of more than 1.5. On Im-10, 202 patients (77%) were assigned as having good/excellent V-LSC (78%), and 161 (61%) were assigned as having Q-LSC of more than 1.5.
CONCLUSION: We concluded that Im-20 can be omitted in at least 61% of the patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19471935     DOI: 10.1007/s00330-009-1467-6

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  17 in total

1.  World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects.

Authors: 
Journal:  Bull World Health Organ       Date:  2003-07-02       Impact factor: 9.408

2.  Imaging characteristics of hepatocellular carcinoma using the hepatobiliary contrast agent Gd-EOB-DTPA.

Authors:  G Jung; J Breuer; L W Poll; J A Koch; T Balzer; S Chang; U Mödder
Journal:  Acta Radiol       Date:  2006-02       Impact factor: 1.990

3.  Conspicuity of liver hemangiomas: short tau inversion recovery, T1, and T2 imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid.

Authors:  Jeffrey M Brody; Leah Schafer; Glenn A Tung; Josy Breuer; Kohkan Shamsi
Journal:  J Magn Reson Imaging       Date:  2005-04       Impact factor: 4.813

4.  Gd-EOB-DTPA enhanced MRI for hepatocellular carcinoma: quantitative evaluation of tumor enhancement in hepatobiliary phase.

Authors:  Kazuhiro Saito; Fumio Kotake; Naoki Ito; Taizo Ozuki; Ryuji Mikami; Kimihiko Abe; Yoko Shimazaki
Journal:  Magn Reson Med Sci       Date:  2005       Impact factor: 2.471

5.  Dynamic MR imaging of liver metastases with Gd-EOB-DTPA.

Authors:  W Stern; F Schick; A F Kopp; P Reimer; K Shamsi; C D Claussen; M Laniado
Journal:  Acta Radiol       Date:  2000-05       Impact factor: 1.990

6.  Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging.

Authors:  B Hamm; T Staks; A Mühler; M Bollow; M Taupitz; T Frenzel; K J Wolf; H J Weinmann; L Lange
Journal:  Radiology       Date:  1995-06       Impact factor: 11.105

7.  Quantitative evaluation of liver function with MRI Using Gd-EOB-DTPA.

Authors:  Hun-Kyu Ryeom; Seong-Hun Kim; Jong-Yeol Kim; Hye-Jeong Kim; Jong-Min Lee; Yong-Min Chang; Yong-Sun Kim; Duk-Sik Kang
Journal:  Korean J Radiol       Date:  2004 Oct-Dec       Impact factor: 3.500

8.  Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial.

Authors:  Christoph J Zech; Luigi Grazioli; Josy Breuer; Maximilian F Reiser; Stefan O Schoenberg
Journal:  Invest Radiol       Date:  2008-07       Impact factor: 6.016

Review 9.  MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA.

Authors:  Christoph J Zech; Karin A Herrmann; Maximilian F Reiser; Stefan O Schoenberg
Journal:  Magn Reson Med Sci       Date:  2007       Impact factor: 2.471

10.  Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions.

Authors:  Renate Hammerstingl; Alexander Huppertz; Josy Breuer; Thomas Balzer; Anthony Blakeborough; Rick Carter; Lluis Castells Fusté; Gertraud Heinz-Peer; Werner Judmaier; Michael Laniado; Riccardo M Manfredi; Didier G Mathieu; Dieter Müller; Koenraad Mortelè; Peter Reimer; Maximilian F Reiser; Philip J Robinson; Kohkan Shamsi; Michael Strotzer; Matthias Taupitz; Bernd Tombach; Gianluca Valeri; Bernhard E van Beers; Thomas J Vogl
Journal:  Eur Radiol       Date:  2007-12-06       Impact factor: 5.315

View more
  27 in total

1.  Chronological evaluation of liver enhancement in patients with chronic liver disease at Gd-EOB-DTPA-enhanced 3-T MR imaging: does liver function correlate with enhancement?

Authors:  Shinichi Nakamura; Kazuo Awai; Daisuke Utsunomiya; Tomohiro Namimoto; Takeshi Nakaura; Kosuke Morita; Yasuyuki Yamashita
Journal:  Jpn J Radiol       Date:  2011-12-14       Impact factor: 2.374

2.  Effects of gadoxetic acid on liver elasticity measurement by using magnetic resonance elastography.

Authors:  Utaroh Motosugi; Tomoaki Ichikawa; Hironobu Sou; Katsuhiro Sano; Ali Muhi; Richard L Ehman; Tsutomu Araki
Journal:  Magn Reson Imaging       Date:  2011-09-19       Impact factor: 2.546

3.  Magnetic resonance imaging: Review of imaging techniques and overview of liver imaging.

Authors:  Santhi Maniam; Janio Szklaruk
Journal:  World J Radiol       Date:  2010-08-28

4.  Quantifying differences in hepatic uptake of the liver specific contrast agents Gd-EOB-DTPA and Gd-BOPTA: a pilot study.

Authors:  O Dahlqvist Leinhard; N Dahlström; J Kihlberg; P Sandström; T B Brismar; O Smedby; P Lundberg
Journal:  Eur Radiol       Date:  2011-10-09       Impact factor: 5.315

5.  Efficacy of liver parenchymal enhancement and liver volume to standard liver volume ratio on Gd-EOB-DTPA-enhanced MRI for estimation of liver function.

Authors:  Tomohide Yoneyama; Yoshihiko Fukukura; Kiyohisa Kamimura; Koji Takumi; Aya Umanodan; Shinichi Ueno; Masayuki Nakajo
Journal:  Eur Radiol       Date:  2013-12-20       Impact factor: 5.315

6.  Gd-EOB-DTPA-enhanced 3.0 T MR imaging: quantitative and qualitative comparison of hepatocyte-phase images obtained 10 min and 20 min after injection for the detection of liver metastases from colorectal carcinoma.

Authors:  Keitaro Sofue; Masakatsu Tsurusaki; Hiroyuki Tokue; Yasuaki Arai; Kazuro Sugimura
Journal:  Eur Radiol       Date:  2011-07-12       Impact factor: 5.315

7.  Optimal timing and diagnostic adequacy of hepatocyte phase imaging with gadoxetate-enhanced liver MRI.

Authors:  Mustafa R Bashir; Steven R Breault; Ryan Braun; Richard K Do; Rendon C Nelson; Scott B Reeder
Journal:  Acad Radiol       Date:  2014-04-06       Impact factor: 3.173

8.  Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading and portal blood flow.

Authors:  Sachiyo Kogita; Yasuharu Imai; Masahiro Okada; Tonsok Kim; Hiromitsu Onishi; Manabu Takamura; Kazuto Fukuda; Takumi Igura; Yoshiyuki Sawai; Osakuni Morimoto; Masatoshi Hori; Hiroaki Nagano; Kenichi Wakasa; Norio Hayashi; Takamichi Murakami
Journal:  Eur Radiol       Date:  2010-05-19       Impact factor: 5.315

9.  Liver perfusion in dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI): comparison of enhancement in Gd-BT-DO3A and Gd-EOB-DTPA in normal liver parenchyma.

Authors:  Hanke J Schalkx; Marijn van Stralen; Kenneth Coenegrachts; Maurice A A J van den Bosch; Charlotte S van Kessel; Richard van Hillegersberg; Karel J van Erpecum; Helena M Verkooijen; Josien P W Pluim; Wouter B Veldhuis; Maarten S van Leeuwen
Journal:  Eur Radiol       Date:  2014-07-05       Impact factor: 5.315

10.  Convolutional neural network-automated hepatobiliary phase adequacy evaluation may optimize examination time.

Authors:  Guilherme Moura Cunha; Kyle A Hasenstab; Atsushi Higaki; Kang Wang; Timo Delgado; Ryan L Brunsing; Alexandra Schlein; Armin Schwartzman; Albert Hsiao; Claude B Sirlin; Katie J Fowler
Journal:  Eur J Radiol       Date:  2020-01-14       Impact factor: 3.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.